These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 28941254)

  • 1. Studies on the Neutralizing Antibody to Herpes Simplex Virus: III. Detection of Type-Specific Antibody by Slow-Reacting Complement-Requiring Neutralizing Antibody Assay.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1982 Jul; 26(7):569-574. PubMed ID: 28941254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the neutralization of herpes simplex virus. XI. Differences between slow-reacting complement-requiring neutralizing (s-CRN) antibodies in IgG and IgM.
    Yoshino K; Urayama M; Abe K
    Microbiol Immunol; 1980; 24(11):1069-77. PubMed ID: 6261091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the neutralization of herpes simplex virus. X. Demonstration of complement-requiring neutralizing (CRN) and slow-reacting CRN (s-CRN) antibodies in late IgG.
    Yoshino K; Isono N; Tada A; Urayama M
    Microbiol Immunol; 1979; 23(10):975-85. PubMed ID: 229389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Type-specificity of slow-reacting complement-requiring neutralizing antibody (s-CRN antibody) to herpes simplex virus types 1 and 2 in rabbits].
    Sekine N
    Uirusu; 1983 Jun; 33(1):47-55. PubMed ID: 6316659
    [No Abstract]   [Full Text] [Related]  

  • 6. A micro-neutralization system for detection of s-CRN antibody to herpes simplex virus.
    Yoshino K; Abe K
    Microbiol Immunol; 1981; 25(10):1037-46. PubMed ID: 6273697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the neutralizing antibody to herpes simplex virus. I. Effect of heterotypic antigenic stimulus on the type specificity of neutralizing antibody in rabbits.
    Ohashi M; Ozaki Y
    Arch Virol; 1981; 67(1):57-69. PubMed ID: 6263224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
    Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
    PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge.
    Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():719-22. PubMed ID: 1312127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cross-immunization on monotypic antibody responses to herpes simplex virus types 1 and 2.
    Smith JW; Glorioso JC
    J Immunol; 1976 Apr; 116(4):898-903. PubMed ID: 176275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
    Slomka MJ
    Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus.
    Mathiesen T; Persson MA; Sundqvist VA; Wahren B
    Clin Exp Immunol; 1988 May; 72(2):211-5. PubMed ID: 2842096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
    Prober CG; Sullender WM; Yasukawa LL; Au DS; Yeager AS; Arvin AM
    N Engl J Med; 1987 Jan; 316(5):240-4. PubMed ID: 3025727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
    Shimizu F; Monma Y; Sekizawa T; Kamiyama K
    J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of herpes virus induced dTk as a marker for serological and direct identification of herpes virus infection in man.
    Gronowitz JS; Källander CF
    Dev Biol Stand; 1982; 52():193-204. PubMed ID: 6299830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2.
    Nick S; Kampe P; Knoblich A; Metzger B; Falke D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1015-24. PubMed ID: 3011967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.